Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Quantum Motion | 2026 | Series C | Undisclosed | London |
| FluoRok | 2026 | Grant | $10.3M | Oxford |
| First Light Fusion | 2026 | Venture - Series Unknown | Undisclosed | Yarnton |
| Theolytics | 2026 | Grant | $9.3M | Oxford |
| PQShield | 2026 | Non Equity Assistance | Undisclosed | Oxford |
| Valink Therapeutics | 2025 | Seed | $11.8M | London |
| Wild Bioscience | 2025 | Series A | $60.4M | Oxford |
| Mode Labs | 2025 | Pre-Seed | $4.0M | Oxford |
| Seloxium | 2025 | Seed | $6.0M | Oxford |
| Alloyed | 2025 | Series B | $47.9M | Yarnton |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Quantum Motion | Series C | Undisclosed | London, United Kingdom |
| 2 | FluoRok | Grant | $10.3M | Oxford, United Kingdom |
| 3 | First Light Fusion | Venture - Series Unknown | Undisclosed | Yarnton, United Kingdom |
| 4 | Theolytics | Grant | $9.3M | Oxford, United Kingdom |
| 5 | PQShield | Non Equity Assistance | Undisclosed | Oxford, United Kingdom |
| 6 | Valink Therapeutics | Seed | $11.8M | London, United Kingdom |
| 7 | Wild Bioscience | Series A | $60.4M | Oxford, United Kingdom |
| 8 | Mode Labs | Pre-Seed | $4.0M | Oxford, United Kingdom |
| 9 | Seloxium | Seed | $6.0M | Oxford, United Kingdom |
| 10 | Alloyed | Series B | $47.9M | Yarnton, United Kingdom |
Quantum Motion develops quantum computing systems based on silicon semiconductor technology used in conventional electronics manufacturing.
FluoRok is revolutionizing the way fluorochemicals are produced globally.
First Light Fusion is an energy company that focuses on researching energy generation by inertial confinement fusion.
Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.
PQShield is a post-quantum cryptography company that develops cryptographic algorithms and protocols to secure technology infrastructures.
Valink Therapeutics is a health care drug discovery for next-generation cancer treatments.
Wild Bioscience is a crop improvement company that provides carbon mitigation, yield enhancement, and farm productivity solutions.
Mode Labs provide robust, continuous, and remote real-time chemical sensors.
Seloxium is innovative research that makes it possible to extract necessary metals in an environmentally friendly manner.
Alloyed develops, licenses, and manufactures proprietary alloys, alloy powders and alloy components.
Mixergy offer a cost-effective solution to save energy and facilitate more renewable power generation.
Salience Labs offers photonic solutions designed to enhance connectivity for AI data center infrastructure.
Caristo Diagnostics is a biotech company that provides diagnostic platforms for heart diseases, stroke, and diabetes.
We are advancing novel antigen modulation technology that controls T cells to guide the immune system.
Oxford Endovascular are developing a novel treatment for treating brain aneurysms.
Oxford Quantum Circuits develops quantum computers designed for breakthrough discoveries.
Proxisense has developed extreme environment proximity sensors and fluid contamination systems.
Building the most advanced global infrastructure for People Science.
Covatic is the use of mobile based algorithms to bring smart personalisation to apps.
OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.
QuantrolOx is building automated machine learning-based control software for quantum technologies to tune, stabilize, and optimize qubits.
Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.
Scripta Therapeutics operates as a bio-tech company.
Fractile is building chips that remove every bottleneck to running large language models at a global scale
Allos is a solution to prognose, monitor, and treat autoimmune conditions.
Oxford Science Enterprises has invested in 84 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Oxford Science Enterprises's top investment sectors include Biotechnology, Health Care, Therapeutics, Software, Hardware. The firm invests across 49 different industry categories.
Among tracked funding rounds, Oxford Quantum Circuits received $100.0M in a Series B round. Oxford Science Enterprises's total known invested capital is $1.3B.
Oxford Science Enterprises's average investment size is $20.4M across its portfolio of 84 companies.
Recent Oxford Science Enterprises portfolio additions include Quantum Motion, FluoRok, First Light Fusion, Theolytics, PQShield. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors